Across TCGA pan-cancer cohorts, LINC00222 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00222 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC00222 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00222 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LAML show a favorable association.
BLCA, LUAD, and UCEC are the cancer types where LINC00222 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.